| Abstract |
[Abstract] Purpose: To observe and explore the related factors of anxiety and depression in patients with bronchial asthma, and to guide clinical targeted interventions. Methods: From January 2021 to April 2023, 100 patients with bronchial asthma who visited our hospital were selected as the survey objects. Their general information was collected, and according to the results of the anxiety and depression evaluation scale (HAD), they were divided into an experimental group (combined anxiety and depression) and a control group (without combined anxiety and depression). The clinical characteristics of the two groups were retrospectively analyzed, and logistic regression was used to analyze the influencing factors of anxiety and depression in patients with bronchial asthma. Results: Among the 100 patients with bronchial asthma, 57 had combined anxiety and depression, accounting for 57.00%. There were significant differences in age, asthma control test (ACT) score, monthly income, educational level, place of residence, asthma grading, and clinical staging between the 57 patients with combined anxiety and depression and the 43 patients without combined anxiety and depression (P<0.05). Logistic regression analysis showed that age ≥60 years, ACT score <20 points, junior high school or below educational level, rural residence, asthma grade 4, and clinical staging were the main influencing factors of anxiety and depression in patients with bronchial asthma (P<0.05). Conclusion: Patients with bronchial asthma are prone to anxiety and depression, which should be highly valued clinically, especially in elderly patients, those with low ACT scores, low educational levels, rural residents, severe asthma, and slow and sustained attacks of bronchial asthma. Active rehabilitation guidance should be provided to promote recovery.
|